Fig. 6 | Scientific Reports

Fig. 6

From: NETosis-based prognostic model reveals immune modulation in clear cell renal cell carcinoma using single-cell and bulk RNA sequencing

Fig. 6

Analysis of gene mutations and immunotherapy. (A) Survival curve of the combined groups. (B) Survival curve of different TME groups. (C, D) Genetic mutation analysis of two groups. (E) Differential immune checkpoint expression among GPR + TME groups. (F) Differential TIDE response rate among GPR + TME groups. (G, H) Differential response rate among GPR + TME groups. (I,J) Downregulated genes in response group and NET-low TME-high group.

Back to article page